Analysts bullish on Boston Scientific's plans for 75 new products by 2022
July 03, 2019 at 06:29 AM EDT
Boston Scientific CEO Michael Mahoney laid out the long-term strategy for the company late last week, including a plan to launch 75 new cardiac valve, brain stimulation and other products by 2022.
